TRIAL LOCATIONS

The European Phase II clinical trial DIAGNODE-2 is admitting recently diagnosed type 1 diabetes patients in selected clinics in Czech Republic, Netherlands, Spain and Sweden.

 

VOLUNTEER TO PARTICIPATE

Contact a member of the study team to volunteer for the clinical trial DIAGNODE-2. Personal data is processed in accordance to applicable law. After enrolling in a study, the participant may leave at any time for any reason. The trial is approved by national competent authorities responsible for human medicine and the Ethics Committees. Further information regarding the trial may be obtained from the clinic.

DIAGNODE-2
COORDINATING INVESTIGATOR
Professor Johnny Ludvigsson
  Linköpings universitet, Sweden
 

A double-blind, placebo-controlled intervention trial, where Diamyd® (GAD-alum) is administrated directly into lymph nodes in combination with vitamin D. The trial evaluate the effectiveness of preserving the insulin producing capacity.


PARTICIPATING CLINICS

Sweden

Linköping
  Universitetssjukhuset
Barn- och Ungdomskliniken
  FULLY RECRUITED
Linköping
  Universitetssjukhuset
Endokrinmedicinska kliniken
  FULLY RECRUITED
Uddevalla
  Uddevalla sjukhus
Barn- och ungdomskliniken
  FULLY RECRUITED
Uddevalla
  Uddevalla sjukhus
Forskningsenheten för Diabetes
  FULLY RECRUITED
Malmö
  Skånes Universitetssjukhus
Endokrinmottagningen
  FULLY RECRUITED
Malmö
  Skånes Universitetssjukhus
Barndiabetesmottagningen
  FULLY RECRUITED
Umeå
  Norrlands Universitetssjukhus
Barnmottagningen
  FULLY RECRUITED

Spain

Barakaldo
  Hospital Universitario Cruces
Coordinador Nacional
  FULLY RECRUITED
Barakaldo
  Hospital Universitario Cruces
Endocrinología y diabetología Pediátrica
  FULLY RECRUITED
Barakaldo
  Hospital Universitario Cruces
Endocrinología y diabetología de Adultos
  FULLY RECRUITED
Barcelona
  Hospital Vall Hebrón
Grupo de Investigación en Diabetes y Metabolismo
  FULLY RECRUITED
Barcelona
  Hospital Vall Hebrón
Endocrinología y diabetología de Adultos
  FULLY RECRUITED
Madrid
  Hospital Ramón y Cajal
Endocrinología y diabetología Pediátrica
  FULLY RECRUITED
Madrid
  Hospital Ramón y Cajal
Endocrinología y diabetología de Adultos
  FULLY RECRUITED
Málaga
  Hospital Materno-Infantil
Endocrinología y diabetología Pediátrica
  FULLY RECRUITED
Málaga
  Hospital Carlos Haya
Endocrinología y diabetología de Adultos
  FULLY RECRUITED
Sevilla
  Hospital Universitario Virgen del Rocío
Endocrinología y diabetología Pediátrica
  FULLY RECRUITED
Sevilla
  Hospital Universitario Virgen Macarena
Endocrinología y diabetología de Adultos
  FULLY RECRUITED
Zaragoza
  Hospital Universitario Miguel Servet
Endocrinología y diabetología Pediátrica
  FULLY RECRUITED
Zaragoza
  Hospital Universitario Miguel Servet
Endocrinología y diabetología de Adultos
  FULLY RECRUITED

Czech Republic

Praha
  Fakultní nemocnice v Motole
Pediatrická klinika
  FULLY RECRUITED
Praha
  Institut klinické a experimentální medicíny (IKEM)
Centrum diabetologie
  FULLY RECRUITED

Netherlands

Rotterdam
  Diabeter
Diabeter
  FULLY RECRUITED
 

SAFETY

Diamyd® has been administered to more than 1,000 patients in clinical trials and has presented a tolerable safety profile